Amy L. Silvers

802 total citations
10 papers, 605 citations indexed

About

Amy L. Silvers is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Amy L. Silvers has authored 10 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Amy L. Silvers's work include Bioactive Compounds and Antitumor Agents (2 papers), Skin Protection and Aging (2 papers) and TGF-β signaling in diseases (2 papers). Amy L. Silvers is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Skin Protection and Aging (2 papers) and TGF-β signaling in diseases (2 papers). Amy L. Silvers collaborates with scholars based in United States, Australia and Canada. Amy L. Silvers's co-authors include Michael Bachelor, G. Timothy Bowden, Andrew C. Chang, David G. Beer, Thomas J. Giordano, Mark B. Orringer, Zhuwen Wang, Dafydd G. Thomas, Christopher W. Seder and G. Tim Bowden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Clinical Cancer Research.

In The Last Decade

Amy L. Silvers

10 papers receiving 591 citations

Peers

Amy L. Silvers
Miyako Okamoto United States
Connie P. Matthews United States
Amy L. Silvers
Citations per year, relative to Amy L. Silvers Amy L. Silvers (= 1×) peers Jian-Li Huang

Countries citing papers authored by Amy L. Silvers

Since Specialization
Citations

This map shows the geographic impact of Amy L. Silvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Silvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Silvers more than expected).

Fields of papers citing papers by Amy L. Silvers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Silvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Silvers. The network helps show where Amy L. Silvers may publish in the future.

Co-authorship network of co-authors of Amy L. Silvers

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Silvers. A scholar is included among the top collaborators of Amy L. Silvers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Silvers. Amy L. Silvers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lin, Lin, Adam J. Bass, William W. Lockwood, et al.. (2012). Activation of GATA binding protein 6 ( GATA6 ) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proceedings of the National Academy of Sciences. 109(11). 4251–4256. 62 indexed citations
2.
Silvers, Amy L., Lin Lin, Adam J. Bass, et al.. (2010). Decreased Selenium-Binding Protein 1 in Esophageal Adenocarcinoma Results from Posttranscriptional and Epigenetic Regulation and Affects Chemosensitivity. Clinical Cancer Research. 16(7). 2009–2021. 61 indexed citations
3.
Silvers, Amy L., Dafydd G. Thomas, Christopher W. Seder, et al.. (2010). Curcumin Promotes Apoptosis, Increases Chemosensitivity, and Inhibits Nuclear Factor κB in Esophageal Adenocarcinoma. Translational Oncology. 3(2). 99–108. 76 indexed citations
4.
Seder, Christopher W., Lin Lin, Amy L. Silvers, et al.. (2009). INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma. Journal of Thoracic Oncology. 4(4). 455–462. 50 indexed citations
5.
Seder, Christopher W., Lin Lin, Amy L. Silvers, et al.. (2009). Upregulated INHBA Expression May Promote Cell Proliferation and Is Associated with Poor Survival in Lung Adenocarcinoma. Neoplasia. 11(4). 388–396. 114 indexed citations
6.
Seder, Christopher W., Guoan Chen, Xiaoju Wang, et al.. (2008). AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma. Journal of Thoracic Oncology. 3(11). 1236–1244. 44 indexed citations
7.
Silvers, Amy L., Joanne S. Finch, & G. Timothy Bowden. (2005). Inhibition of UVA‐induced c‐Jun N‐terminal Kinase Activity Results in Caspase‐dependent Apoptosis in Human Keratinocytes. Photochemistry and Photobiology. 82(2). 423–431. 10 indexed citations
8.
Silvers, Amy L., Michael Bachelor, & G. Timothy Bowden. (2003). The Role of JNK and p38 MAPK Activities in UVA-Induced Signaling Pathways Leading to AP-1 Activation and c-Fos Expression. Neoplasia. 5(4). 319–329. 106 indexed citations
9.
Bachelor, Michael, Amy L. Silvers, & G. Tim Bowden. (2002). The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT. Oncogene. 21(46). 7092–7099. 56 indexed citations
10.
Silvers, Amy L. & G. Timothy Bowden. (2002). UVA Irradiation-induced Activation of Activator Protein-1 is Correlated with Induced Expression of AP-1 Family Members in the Human Keratinocyte Cell Line HaCaT¶. Photochemistry and Photobiology. 75(3). 302–302. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026